Chugai Pharmaceutical Co., Ltd.
JPX: 4519.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Osamu Okuda
- Employees
- 5,026
- Headquarters
- Tokyo, Japan
- IPO year
- 2000
- Market cap
- ¥13T
- Website
- https://www.chugai-pharm.co.jp
Loading 4519…
Loading profile data…Frequently asked questions about 4519
What does Chugai Pharmaceutical Co., Ltd. (4519.T) do?
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; ost...
Where does 4519.T trade?
Chugai Pharmaceutical Co., Ltd. (4519.T) trades on the Tokyo Stock Exchange.
What sector is 4519.T in?
Chugai Pharmaceutical Co., Ltd. (4519.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Chugai Pharmaceutical Co., Ltd.?
Osamu Okuda is the chief executive officer of Chugai Pharmaceutical Co., Ltd. (4519.T).
Where is Chugai Pharmaceutical Co., Ltd. headquartered?
Chugai Pharmaceutical Co., Ltd. is headquartered in Japan.
Does 4519.T pay a dividend?
Yes — Chugai Pharmaceutical Co., Ltd. (4519.T) paid a trailing twelve-month dividend of JPY 272.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4519.T go public?
Chugai Pharmaceutical Co., Ltd. (4519.T) completed its initial public offering in 2000.